Teleflex acquires substantially all of BIOTRONIK Vascular Intervention business

The BIOTRONIK Vascular Intervention business, with the exception of IMDS products has been acquired by Teleflex, effective as of July 1st, 2025. These products are now part of the Teleflex portfolio. For questions or further information relating to the Vascular Intervention portfolio, please complete the contact form below.

Coronary Drug-Eluting Stent System

Coronary drug-eluting stent (DES) systems are stents which are pre-mounted on a balloon catheter. DES are used for the treatment of coronary arteries and release an anti-proliferative drug to the vessel wall.